Background: The aim of the study was to determine if routine detailed screening tests in healthy children are needed or not.Methods: A total of 590 healthy children (mean age: 9.7±2.9 years, M/F: 286/304) who were referred from primary careproviders for screening tests were evaluated retrospectively in terms of laboratory findings such as complete blood count,lipid profiles, liver and kidney function tests. Results: Iron deficiency anemia was significantly more common in teenagegirls than boys. Only 16.7% of girls and 16.4% of boys had lipid abnormalities. The other biochemical parameters werewithin normal limits in both groups. Conclusions: No significant difference was observed in biochemical parameters inhealthy children. Thus, unnecessary tests should not be done in healthy children by primary care physicians.
Amaç: Çalışmanın amacı sağlıklı çocuklarda rutin ayrıntılı tarama testlerine gerek olup olmadığını değerlendirmektir. Gereç ve yöntem: Çalışmaya aile hekimleri tarafından tarama testlerinin yapılması için tarafımıza yönlendirilen 590 sağlıklı çocuk (ortalama yaş: 9.7±2,9 yıl, E/K:286/304) alınmıştır. Çalışılan test sonuçları (tam kan sayımı, lipit düzeyleri, karaciğer ve böbrek fonksiyon testleri, tiroid testleri) retrospektif olarak değerlendirilmiştir. Bulgular: Demir eksikliğine bağlı anemi ergen kız çocuklarında erkeklere oranla daha sık saptanmıştır. Lipit bozuklukları kızlarda %16,7, erkeklerde %16,4 oranında saptanmıştır. Diğer biyokimyasal parametreler normal tespit edilmiştir. Sonuç: Sağlıklı çocuklarda ayrıntılı biyokimyasal testler açısından istatistiksel olarak anlamlı patoloji saptanmamıştır. Bu nedenle, maliyet de düşünüldüğünde aile hekimleri tarafından gereksiz testler istenilmemeli ve bu konuda aile hekimleri bilgilendirilmelidir.
___
1. Minkovitz C, Wissow L. Evaluating and using laboratory tests. In: Oski's Pediatrics. Principles and Practice, 4th, McMillan JA, Feigin RD, DeAngelis C, Jones MD (Eds), Lippincott Williams & Wilkins, Philadelphia 2006. p.95.
2. The Guide to Clinical Preventive Services 2014: Recommendations of the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 May. Clinical Summaries of Recommendations for Children and Adolescents. Available from: https://www.ncbi.nlm.nih.gov/books/NBK2358 50. Accessed date: 05.05. 2018.
3. U.S. Preventive Services Task Force. The Guide to Clinical Preventive Services 2010 - 2011: Recommendations of the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 Aug. Available from: https://www.ncbi.nlm.nih.gov/books/NBK5670 7/ Accessed date:01.05.2018.
4. The Guide to Clinical Preventive Services 2012: Recommendations of the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Oct. Recommendations for Children and Adolescents. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1151 19/ Accessed date: 3.05.2018.
5. Simon GR, Baker C, Barden GA III, et al. 2014 recommendations for pediatric preventive health care. Pediatrics. 2014;133(3):568–570.
6. Committee on Practice and Ambulatory Medicine, Bright Futures Periodicity Schedule Workgroup/American Academy of Pediatrics. Recommendations for Preventive Pediatric Health Care - Periodicity Schedule. Pediatrics. 2017;139(4). pii: e20170254. doi: 10.1542/peds.2017-0254. www.aap.org/en- us/professional-resources/practicesupport/Pages/PeriodicitySchedule.aspx Pediatrics 2017 Accessed date:04.05.2018.
7. Bright Futures Steering Committee. Bright Futures guidelines for health supervision of infants, children, and adolescents. Middle childhood. http://brightfutures.aap.org/pdfs/Guidelines_P DF/17-Middle_Childhood.pdf. Accessed date: 04.05.2018.
8. Geoffrey R Simon, Cynthia Baker, Graham A Barden 3rd, Brown OW, Hardin A, Lessin HR, Meade K, Moore S, Rodgers CT; Committee on Practice and Ambulatory Medicine, Curry ES, Dunca PM, Hagan JF Jr, Kemper AR, Shaw JS, Swanson JT; Bright Futures Periodicity Schedule Workgroup. 2014 recommendations for pediatric preventive health care. Pediatrics. 2014;133(3):568-70. doi: 10.1542/peds.2013-4096.
9. Behrman RE, Kliegman RM, editors:Nelson Essentials of Pediatrics, 4th edition, Philadelphia, 2002, WB Saunders, chapter 1;2- 4 pp.
10. Levine D. Evaluation of the Well Child section 2 Growth and Development, Nelson Essentials of Pediatrics, 6th edition, Philadelphia, 2006, WB Saunders, chapter 9 ;24-28 pp.
11. Neyzi O, Ertuğrul T, Pediatri Cilt 1. Gökçay G, Neyzi O, Bulut A, Sağlam Çocuk İzlemi, Nobel Tıp Kitabevi.2002; 3: 49-56.
12. Özdemir N. Iron deficiency anemia from diagnosis to treatment in children. Turk Pediatri Ars. 2015; 50(1):11-9.
13. World Health Organization. Iron deficiency anaemia assessment, prevention, and control. A guide for programme managers. Geneva (Switzerland): World Health Organization; 2001, pp 114.
14. Koyuncuoğlu Güngör N. Overweight and Obesity in Children and Adolescents. Journal of Clinical Research in Pediatric Endocrinology. 2014;6(3):129-143. doi:10.4274/jcrpe.1471.
15. Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53(1):68-75.
16. Schillie S, Murphy TV, Sawyer M, et al. CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management. Morb Mortal Wkly Rep Recomm Rep 2013;62;1-19.
17. Grossman DC, Moyer VA, Melnyk BM, Chou R, DeWitt TG; U.S. Preventive Services Task Force. The anatomy of a U.S. Preventive Services Task Force recommendation: lipid screening for children and adolescents. Arch Pediatr Adolesc Med. 2011;165(3):205–210.
18. Lin KW. What to Do at Well-Child Visits: The AAFP's Perspective. Am Fam Physician. 2015 ;91(6):362-4.
19. Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN Clinical Practice Guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 2017;64:319‐334.
20. Mitnikos T, Kohli R. Pediatric nonalcoholic fatty liver disease. Clin Liver Dis. 2018;11(4):95-97.
21. National Heart, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011;128 (Suppl. 2011;128(Suppl 5):213–256.
22. American Academy of Family Physicians. Summary of recommendations for clinical preventive services. July 2014. https://www.aafp.org/dam/AAFP/documents/p atient_care/clinical_recommendations/cpsrecommendations.pdf. Accessed date: 02.05.2018.
23. Gür E, Yıldız I, Celkan T. Prevalence of anemia and the risk factors among school children in İstanbul. J Trop Pediatr. 2005;51:346-50.